Literature DB >> 11548862

The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.

A Forster1, J Hempenstall, T Rades.   

Abstract

The aim of this study was to investigate the use of small-scale fusion experiments and the Gordon-Taylor (GT) equation to predict whether melt extrusion of a drug with an amorphous polymer produces a stable amorphous dispersion with increased drug dissolution. Indomethacin, lacidipine, nifedipine, piroxicam, and tolbutamide were used as poorly soluble drugs. Drug/polyvinylpyrrolidone (PVP) blends were prepared at a 1:1 mass ratio. Small-scale fusion experiments were performed in a differential scanning calorimeter (DSC) and in stainless steel beakers. Extrusion was performed in a Brabender Plasti-corder. The glass transition temperatures Tg were determined by DSC. Taking an average Tg from the DSC melt, beaker melt, and GT equation accurately predicted the extrudate Tg. Physical stability of beaker melt and extrudate samples was tested by X-ray powder diffraction (XRPD) and DSC after storage at 30 degrees C (beaker melt) or 25 degrees C (extrudate) and less than 10%, 60%, and 75% relative humidity, (RH). Beaker melts were amorphous, apart from some residual crystallinity. Extrudates were amorphous after preparation. Except for indomethacin/PVP, which remained amorphous, the crystallinity of beaker melts and extrudates increased only at 75% RH. Recrystallization occurred even when the Tg of the sample was well above the storage temperature. Chemical stability of the beaker melts and extrudates was tested by capillary electrophoresis and high-performance liquid chromatography (HPLC). Stability was slightly improved in the extrudate compared to the beaker melt. In general, the order for rate of dissolution was crystalline drug was less than the physical mixture, which was less than the drug/PVP beaker melt, which was approximately equal to the extrudate. The use of beaker melts allows a conservative estimate of the potential to melt extrude a drug. To predict physical stability, analysis of the Tg must be combined with physical stability experiments.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11548862     DOI: 10.1081/ddc-100105180

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  11 in total

1.  Fast surface crystallization of amorphous griseofulvin below T g.

Authors:  Lei Zhu; Janan Jona; Karthik Nagapudi; Tian Wu
Journal:  Pharm Res       Date:  2010-04-23       Impact factor: 4.200

2.  A new twist in the old story-can compression induce mixing of phase separated solid dispersions? A case study of spray-dried miconazole-PVP VA64 solid dispersions.

Authors:  Abhishek Singh; Jan Van Humbeeck; Guy Van den Mooter
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

3.  An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.

Authors:  Sujinda Keratichewanun; Yasuo Yoshihashi; Narueporn Sutanthavibul; Katsuhide Terada; Jittima Chatchawalsaisin
Journal:  Pharm Res       Date:  2015-02-12       Impact factor: 4.200

Review 4.  Hot-Melt Extrusion: a Roadmap for Product Development.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  AAPS PharmSciTech       Date:  2021-06-17       Impact factor: 3.246

5.  Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.

Authors:  Anh Q Vo; Xin Feng; Manjeet Pimparade; Xinyou Ye; Dong Wuk Kim; Scott T Martin; Michael A Repka
Journal:  Eur J Pharm Sci       Date:  2017-02-28       Impact factor: 4.384

6.  Electrolyte-stimulated biphasic dissolution profile and stability enhancement for tablets containing drug-polyelectrolyte complexes.

Authors:  Christoph Kindermann; Karin Matthée; Frank Sievert; Jörg Breitkreutz
Journal:  Pharm Res       Date:  2012-01-07       Impact factor: 4.200

7.  A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.

Authors:  Meiling Su; Yanming Xia; Yajing Shen; Weili Heng; Yuanfeng Wei; Linghe Zhang; Yuan Gao; Jianjun Zhang; Shuai Qian
Journal:  RSC Adv       Date:  2020-01-02       Impact factor: 4.036

Review 8.  Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products.

Authors:  Palpandi Pandi; Raviteja Bulusu; Nagavendra Kommineni; Wahid Khan; Mandip Singh
Journal:  Int J Pharm       Date:  2020-06-18       Impact factor: 5.875

9.  Rapid assessment of homogeneity and stability of amorphous solid dispersions by atomic force microscopy--from bench to batch.

Authors:  Matthias E Lauer; Monira Siam; Joseph Tardio; Susanne Page; Johannes H Kindt; Olaf Grassmann
Journal:  Pharm Res       Date:  2013-05-15       Impact factor: 4.200

10.  Development of micro-fibrous solid dispersions of poorly water-soluble drugs in sucrose using temperature-controlled centrifugal spinning.

Authors:  Stefania Marano; Susan Anne Barker; Bahijja Tolulope Raimi-Abraham; Shahrzad Missaghi; Ali Rajabi-Siahboomi; Duncan Q M Craig
Journal:  Eur J Pharm Biopharm       Date:  2016-03-21       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.